{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T01:10:15Z","timestamp":1792113015664,"version":"4.4.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2016,9,23]],"date-time":"2016-09-23T00:00:00Z","timestamp":1474588800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"crossref","award":["POIG. 01.01.02-12-004\/09-00"],"award-info":[{"award-number":["POIG. 01.01.02-12-004\/09-00"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1007\/s12035-016-0124-8","type":"journal-article","created":{"date-parts":[[2016,9,22]],"date-time":"2016-09-22T22:15:24Z","timestamp":1474582524000},"page":"5883-5893","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":54,"title":["Associations of Serum Cytokine Receptor Levels with Melancholia, Staging of Illness, Depressive and Manic Phases, and Severity of Depression in Bipolar Disorder"],"prefix":"10.1007","volume":"54","author":[{"given":"Marcin","family":"Siwek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Sowa-Ku\u0107ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krzysztof","family":"Stycze\u0144","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulina","family":"Misztak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafa\u0142 J.","family":"Nowak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernadeta","family":"Szewczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominika","family":"Dudek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janusz K.","family":"Rybakowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Nowak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Maes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,9,23]]},"reference":[{"issue":"4","key":"124_CR1","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0165-0327(95)00028-L","volume":"34","author":"M Maes","year":"1995","unstructured":"Maes M, Meltzer HY, Bosmans E, Bergmans R, Vandoolaeghe E, Ranjan R, Desnyder R (1995) Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression. J Affect Disord 34(4):301\u2013309","journal-title":"J Affect Disord"},{"issue":"2","key":"124_CR2","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0022-3956(94)00049-W","volume":"29","author":"M Maes","year":"1995","unstructured":"Maes M, Bosmans E, Calabrese J, Smith R, Meltzer HY (1995) Interleukin-2 and interleukin-6 in schizophrenia and mania: effects of neuroleptics and mood stabilizers. J Psychiatr Res 29(2):141\u2013152","journal-title":"J Psychiatr Res"},{"issue":"1","key":"124_CR3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-1781(96)02915-0","volume":"66","author":"M Maes","year":"1997","unstructured":"Maes M, Delange J, Ranjan R, Meltzer HY, Desnyder R, Cooremans W, Scharp\u00e9 S (1997) Acute phase proteins in schizophrenia, mania and major depression: modulation by psychotropic drugs. Psychiatry Res 66(1):1\u201311","journal-title":"Psychiatry Res"},{"issue":"4","key":"124_CR4","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1600-0447.1991.tb03163.x","volume":"84","author":"M Maes","year":"1991","unstructured":"Maes M, Bosmans E, Suy E, Vandervorst C, DeJonckheere C, Raus J (1991) Depression-related disturbances in mitogen-induced lymphocyte responses and interleukin-1 beta and soluble interleukin-2 receptor production. Acta Psychiatr Scand 84(4):379\u2013386","journal-title":"Acta Psychiatr Scand"},{"key":"124_CR5","doi-asserted-by":"crossref","unstructured":"Maes M, Lambrechts J, Bosmans E, Jacobs J, Suy E, Vandervorst C, de Jonckheere C, Minner B et al (1992) Evidence for a systemic immune activation during depression: results of leukocyte enumeration by flow cytometry in conjunction with monoclonal antibody staining. Psychol Med 22(1):45\u201353","DOI":"10.1017\/S0033291700032712"},{"key":"124_CR6","doi-asserted-by":"crossref","unstructured":"Maes M, Scharpe S, Bosmans E, Vandewoude M, Suy E, Uyttenbroeck W, Cooreman W, Vandervorst C et al (1992) Disturbances in acute phase plasma proteins during melancholia: additional evidence for the presence of an inflammatory process during that illness. Prog Neuro-Psychopharmacol Biol Psychiatry 16(4):501\u2013515","DOI":"10.1016\/0278-5846(92)90056-K"},{"issue":"3","key":"124_CR7","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0165-0327(94)90012-4","volume":"32","author":"MH Rapaport","year":"1994","unstructured":"Rapaport MH (1994) Immune parameters in euthymic bipolar patients and normal volunteers. J Affect Disord 32(3):149\u2013156","journal-title":"J Affect Disord"},{"issue":"2\u20133","key":"124_CR8","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jad.2005.11.015","volume":"90","author":"SM O\u2019Brien","year":"2006","unstructured":"O\u2019Brien SM, Scully P, Scott LV, Dinan TG (2006) Cytokine profiles in bipolar affective disorder: focus on acutely ill patients. J Affect Disord 90(2\u20133):263\u2013267","journal-title":"J Affect Disord"},{"issue":"1\u20133","key":"124_CR9","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jad.2007.02.018","volume":"104","author":"YK Kim","year":"2007","unstructured":"Kim YK, Jung HG, Myint AM, Kim H, Park SH (2007) Imbalance between pro-inflammatory and anti-inflammatory cytokines in bipolar disorder. J Affect Disord 104(1\u20133):91\u201395","journal-title":"J Affect Disord"},{"issue":"2","key":"124_CR10","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s00406-010-0116-z","volume":"261","author":"IG Barbosa","year":"2011","unstructured":"Barbosa IG, Huguet RB, Mendon\u00e7a VA, Sousa LP, Neves FS, Bauer ME, Teixeira AL (2011) Increased plasma levels of soluble TNF receptor I in patients with bipolar disorder. Eur Arch Psychiatry Clin Neurosci 261(2):139\u2013143","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"issue":"1","key":"124_CR11","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.biopsych.2013.01.007","volume":"74","author":"A Modabbernia","year":"2013","unstructured":"Modabbernia A, Taslimi S, Brietzke E, Ashrafi M (2013) Cytokine alterations in bipolar disorder: a meta-analysis of 30 studies. Biol Psychiatry 74(1):15\u201325","journal-title":"Biol Psychiatry"},{"issue":"9","key":"124_CR12","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.jpsychires.2013.05.018","volume":"47","author":"K Munkholm","year":"2013","unstructured":"Munkholm K, Bra\u00fcner JV, Kessing LV, Vinberg M (2013) Cytokines in bipolar disorder vs. healthy control subjects: a systematic review and meta-analysis. J Psychiatr Res 47(9):1119\u20131133","journal-title":"J Psychiatr Res"},{"key":"124_CR13","doi-asserted-by":"crossref","unstructured":"Berk M, Kapczinski F, Andreazza AC, Dean OM, Giorlando F, Maes M, Y\u00fccel M, Gama CS et al (2011) Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors. Neurosci Biobehav Rev 35(3):804\u2013817","DOI":"10.1016\/j.neubiorev.2010.10.001"},{"issue":"2","key":"124_CR14","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s11920-014-0541-1","volume":"17","author":"G Anderson","year":"2015","unstructured":"Anderson G, Maes M (2015) Bipolar disorder: role of immune-inflammatory cytokines, oxidative and nitrosative stress and tryptophan catabolites. Curr Psychiatry Rep 17(2):8","journal-title":"Curr Psychiatry Rep"},{"issue":"6","key":"124_CR15","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1111\/j.1399-5618.2007.00493.x","volume":"9","author":"A Ortiz-Dom\u00ednguez","year":"2007","unstructured":"Ortiz-Dom\u00ednguez A, Hern\u00e1ndez ME, Berlanga C, Guti\u00e9rrez-Mora D, Moreno J, Heinze G, Pav\u00f3n L (2007) Immune variations in bipolar disorder: phasic differences. Bipolar Disord 9(6):596\u2013602","journal-title":"Bipolar Disord"},{"issue":"3","key":"124_CR16","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.jad.2008.12.001","volume":"116","author":"E Brietzke","year":"2009","unstructured":"Brietzke E, Stertz L, Fernandes BS, Kauer-Sant\u2019anna M, Mascarenhas M, Escosteguy Vargas A, Chies JA, Kapczinski F (2009) Comparison of cytokine levels in depressed, manic and euthymic patients with bipolar disorder. J Affect Disord 116(3):214\u2013217","journal-title":"J Affect Disord"},{"issue":"2","key":"124_CR17","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/hup.2301","volume":"28","author":"O Doganavsargil-Baysal","year":"2013","unstructured":"Doganavsargil-Baysal O, Cinemre B, Aksoy UM, Akbas H, Metin O, Fettahoglu C, Gokmen Z, Davran F (2013) Levels of TNF-\u03b1, soluble TNF receptors (sTNFR1, sTNFR2), and cognition in bipolar disorder. Hum Psychopharmacol 28(2):160\u2013167","journal-title":"Hum Psychopharmacol"},{"key":"124_CR18","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jad.2014.05.009","volume":"166","author":"YM Bai","year":"2014","unstructured":"Bai YM, Su TP, Tsai SJ, Wen-Fei C, Li CT, Pei-Chi T, Mu-Hong C (2014) Comparison of inflammatory cytokine levels among type I\/type II and manic \/hypomanic\/euthymic\/depressive states of bipolar disorder. J Affect Disord 166:187\u2013192","journal-title":"J Affect Disord"},{"key":"124_CR19","doi-asserted-by":"crossref","unstructured":"Monfrim X, Gazal M, De Leon PB, Quevedo L, Souza LD, Jansen K, Oses JP, Pinheiro RT et al (2014) Immune dysfunction in bipolar disorder and suicide risk: is there an association between peripheral corticotropin-releasing hormone and interleukin-1\u03b2? Bipolar Disord 16(7):741\u2013747","DOI":"10.1111\/bdi.12214"},{"issue":"2","key":"124_CR20","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1159\/000346112","volume":"67","author":"A Rafiei","year":"2013","unstructured":"Rafiei A, Hosseini SH, Taheri M, Hosseni-khah Z, Hajilooi M, Mazaheri Z (2013) Influence of IL-1RN intron 2 variable number of tandem repeats (VNTR) polymorphism on bipolar disorder. Neuropsychobiology 67(2):116\u2013121","journal-title":"Neuropsychobiology"},{"key":"124_CR21","doi-asserted-by":"crossref","unstructured":"Grande I, Magalh\u00e3es PV, Chendo I, Stertz L, Panizutti B, Colpo GD, Rosa AR, Gama CS et al (2014) Staging bipolar disorder: clinical, biochemical, and functional correlates. Acta Psychiatr Scand 129(6):437\u2013444","DOI":"10.1111\/acps.12268"},{"key":"124_CR22","doi-asserted-by":"crossref","unstructured":"Hope S, Ueland T, Steen NE, Dieset I, Lorentzen S, Berg AO, Agartz I, Aukrust P et al (2013) Interleukin 1 receptor antagonist and soluble tumor necrosis factor receptor 1 are associated with general severity and psychotic symptoms in schizophrenia and bipolar disorder. Schizophr Res 145(1\u20133):36\u201342","DOI":"10.1016\/j.schres.2012.12.023"},{"key":"124_CR23","doi-asserted-by":"publisher","unstructured":"American Psychiatric Association (2000) Diagnostic and statistical manual of mental disorders (4th ed., text rev.). doi: 10.1176\/appi.books.9780890423349","DOI":"10.1176\/appi.books.9780890423349"},{"key":"124_CR24","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1192\/bjp.134.4.382","volume":"134","author":"SA Montgomery","year":"1979","unstructured":"Montgomery SA, Asberg M (1979) A new depression scale designed to be sensitive to change. Br J Psychiatry 134:382\u2013389","journal-title":"Br J Psychiatry"},{"key":"124_CR25","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","volume":"23","author":"M Hamilton","year":"1960","unstructured":"Hamilton M (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56\u201362","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"124_CR26","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1192\/bjp.133.5.429","volume":"133","author":"RC Young","year":"1978","unstructured":"Young RC, Biggs JT, Ziegler VE, Meyer DA (1978) A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 133:429\u2013435","journal-title":"Br J Psychiatry"},{"key":"124_CR27","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1586\/ern.09.31","volume":"9","author":"F Kapczinski","year":"2009","unstructured":"Kapczinski F, Dias VV, Kauer-Sant\u2019Anna M, Frey BN, Grassi-Oliveira R, Colom F, Berk M (2009) Clinical implications of a staging model for bipolar disorders. Expert Rev Neurother 9:957\u2013966","journal-title":"Expert Rev Neurother"},{"key":"124_CR28","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1016\/j.pnpbp.2009.07.027","volume":"33","author":"F Kapczinski","year":"2009","unstructured":"Kapczinski F, Dias VV, Kauer-Sant\u2019Anna M, Brietzke E, V\u00e1zquez GH, Vieta E, Berk M (2009) The potential use of biomarkers as an adjunctive tool for staging bipolar disorder. Prog Neuro-Psychopharmacol Biol Psychiatry 33:1366\u20131371","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"124_CR29","doi-asserted-by":"crossref","unstructured":"Powell TR, McGuffin P, D\u2019Souza UM, Cohen-Woods S, Hosang GM, Martin C, Matthews K, Day RK et al (2014) Putative transcriptomic biomarkers in the inflammatory cytokine pathway differentiate major depressive disorder patients from control subjects and bipolar disorder patients. PLoS One 9(3):e91076","DOI":"10.1371\/journal.pone.0091076"},{"key":"124_CR30","doi-asserted-by":"publisher","DOI":"10.1111\/bdi.12320","author":"GN Pandey","year":"2015","unstructured":"Pandey GN, Ren X, Rizavi HS, Zhang H (2015) Abnormal gene expression of proinflammatory cytokines and their receptors in the lymphocytes of patients with bipolar disorder. Bipolar Disord. doi: 10.1111\/bdi.12320","journal-title":"Bipolar Disord"},{"issue":"1","key":"124_CR31","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.psychres.2011.12.007","volume":"198","author":"D Karlovi\u0107","year":"2012","unstructured":"Karlovi\u0107 D, Serretti A, Vrki\u0107 N, Martinac M, Mar\u010dinko D (2012) Serum concentrations of CRP, IL-6, TNF-\u03b1 and cortisol in major depressive disorder with melancholic or atypical features. Psychiatry Res 198(1):74\u201380","journal-title":"Psychiatry Res"},{"key":"124_CR32","doi-asserted-by":"crossref","unstructured":"Celik C, Erdem M, Cayci T, Ozdemir B, Ozgur Akgul E, Kurt YG, Yaman H, Isintas M et al (2010) The association between serum levels of neopterin and number of depressive episodes of major depression. Prog Neuro-Psychopharmacol Biol Psychiatry 34(2):372\u2013375","DOI":"10.1016\/j.pnpbp.2010.01.002"},{"issue":"1","key":"124_CR33","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.pnpbp.2011.09.006","volume":"36","author":"M Maes","year":"2012","unstructured":"Maes M, Mihaylova I, Kubera M, Ringel K (2012) Activation of cell-mediated immunity in depression: association with inflammation, melancholia, clinical staging and the fatigue and somatic symptom cluster of depression. Prog Neuro-Psychopharmacol Biol Psychiatry 36(1):169\u2013175","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"issue":"8","key":"124_CR34","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1016\/j.neubiorev.2013.04.014","volume":"37","author":"SO Nunes","year":"2013","unstructured":"Nunes SO, Vargas HO, Prado E, Barbosa DS, de Melo LP, Moylan S, Dodd S, Berk M (2013) The shared role of oxidative stress and inflammation in major depressive disorder and nicotine dependence. Neurosci Biobehav Rev 37(8):1336\u20131345","journal-title":"Neurosci Biobehav Rev"},{"key":"124_CR35","doi-asserted-by":"crossref","unstructured":"Vargas HO, Nunes SO, Pizzo de Castro M, Bortolasci CC, Sabbatini Barbosa D, Kaminami Morimoto H, Venugopal K, Dodd S et al (2013) Oxidative stress and lowered total antioxidant status are associated with a history of suicide attempts. J Affect Disord 150(3):923\u2013930","DOI":"10.1016\/j.jad.2013.05.016"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12035-016-0124-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-016-0124-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-016-0124-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,13]],"date-time":"2019-09-13T18:45:08Z","timestamp":1568400308000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12035-016-0124-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,23]]},"references-count":35,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["124"],"URL":"https:\/\/doi.org\/10.1007\/s12035-016-0124-8","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,23]]}}}